You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Cell and Gene Therapy Manufacturing QC Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Market Analysis and Insights: Global Cell and Gene Therapy Manufacturing QC Market
The global Cell and Gene Therapy Manufacturing QC market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy Manufacturing QC market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell and Gene Therapy Manufacturing QC market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell and Gene Therapy Manufacturing QC market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell and Gene Therapy Manufacturing QC market.
Cell and Gene Therapy Manufacturing QC Breakdown Data by Type
Safety Testing
Purity Testing
Potency Testing
Identity Testing
Stability Testing
Cell and Gene Therapy Manufacturing QC Breakdown Data by Application
Precision Therapy
Biological Research
Based on regional and country-level analysis, the Cell and Gene Therapy Manufacturing QC market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Cell and Gene Therapy Manufacturing QC market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Bio-Techne Corporation
BioMerieux SA
Catalent, Inc.
Charles River Laboratories International Inc.
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Intertek Group plc
Lonza Group AG
Merck KGaA
Sartorius AG
SGS S.A.
Sistemic Scotland Limited
Thermo Fisher Scientific Inc.
Vigene Biosciences, Inc.
WuXi AppTec
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Safety Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Stability Testing
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Precision Therapy
1.3.3 Biological Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2016-2027)
2.2 Cell and Gene Therapy Manufacturing QC Growth Trends by Regions
2.2.1 Cell and Gene Therapy Manufacturing QC Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Share by Regions (2016-2021)
2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Regions (2022-2027)
2.3 Cell and Gene Therapy Manufacturing QC Industry Dynamic
2.3.1 Cell and Gene Therapy Manufacturing QC Market Trends
2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2016-2021)
3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2016-2021)
3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing QC Revenue
3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2020
3.5 Cell and Gene Therapy Manufacturing QC Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing QC Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Manufacturing QC Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2016-2021)
4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2022-2027)

5 Cell and Gene Therapy Manufacturing QC Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2016-2021)
5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
6.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type
6.2.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
6.2.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
6.2.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application
6.3.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
6.3.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
6.3.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
6.4 North America Cell and Gene Therapy Manufacturing QC Market Size by Country
6.4.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
6.4.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
7.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type
7.2.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
7.2.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
7.2.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application
7.3.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
7.3.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
7.3.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
7.4 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country
7.4.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
7.4.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
9.2.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
9.2.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
9.3.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
9.3.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
9.4 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
9.4.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Details
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.1.5 Bio-Techne Corporation Recent Development
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Details
11.2.2 BioMerieux SA Business Overview
11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.2.5 BioMerieux SA Recent Development
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Details
11.3.2 Catalent, Inc. Business Overview
11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.3.5 Catalent, Inc. Recent Development
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Details
11.4.2 Charles River Laboratories International Inc. Business Overview
11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.4.5 Charles River Laboratories International Inc. Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Details
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.5.5 Eurofins Scientific SE Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Details
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Intertek Group plc
11.7.1 Intertek Group plc Company Details
11.7.2 Intertek Group plc Business Overview
11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.7.5 Intertek Group plc Recent Development
11.8 Lonza Group AG
11.8.1 Lonza Group AG Company Details
11.8.2 Lonza Group AG Business Overview
11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.8.5 Lonza Group AG Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.9.5 Merck KGaA Recent Development
11.10 Sartorius AG
11.10.1 Sartorius AG Company Details
11.10.2 Sartorius AG Business Overview
11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.10.5 Sartorius AG Recent Development
11.11 SGS S.A.
11.11.1 SGS S.A. Company Details
11.11.2 SGS S.A. Business Overview
11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.11.5 SGS S.A. Recent Development
11.12 Sistemic Scotland Limited
11.12.1 Sistemic Scotland Limited Company Details
11.12.2 Sistemic Scotland Limited Business Overview
11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.12.5 Sistemic Scotland Limited Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Details
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
11.14 Vigene Biosciences, Inc.
11.14.1 Vigene Biosciences, Inc. Company Details
11.14.2 Vigene Biosciences, Inc. Business Overview
11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.14.5 Vigene Biosciences, Inc. Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.15.5 WuXi AppTec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 105